A reanalysis of Sweden’s population-based fecal occult blood test (FOBT) screening program suggests that the mortality benefit of colorectal cancer screening may have been substantially underestimated. Researchers analyzed 376,511 adults aged 60–69 years in the Stockholm-Gotland region, using a prospective cohort design in which birth…
Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting…
Olympus’ $1M+ equipment grant to ASGE isn’t just philanthropy—it’s a strategic investment in shaping the next generation of endoscopists and,…
Walgreens is taking colorectal cancer screening out of the clinic and into retail—partnering with Exact Sciences to offer Cologuard access…
This study evaluates the analytical reliability of direct-to-consumer (DTC) gut microbiome testing services. As consumer interest in gut health rises,…
DDW 2026
Several studies presented at DDW 2026 highlighted emerging approaches that could reshape…
A structured triage system for interventional GI referrals changed the originally requested…
Headlines in GI
A routine endoscope demonstration at a Texas hospital allegedly turned into a…
Thought Leadership
In a wide-ranging interview, Byron L. Cryer, MD, president of the American Gastroenterological Association and chairman of internal medicine at Baylor University Medical Center,…
The hidden cost of administrative work extends far beyond unpaid overtime, according…
The microbiome field is undergoing a fundamental shift—from cataloging which microbes are…
As direct-to-consumer microbiome testing becomes more popular, clinicians are calling for stronger…